Trastuzumab is a monoclonal antibody used to treat certain types of breast cancer. It is used to treat HER2-positive breast cancer, which is a type of cancer that has a higher than normal amount of a protein called HER2. Trastuzumab works by blocking the HER2 protein, which helps to slow or stop the growth of cancer cells. It is usually given in combination with other chemotherapy drugs. Trastuzumab is typically given intravenously, and can be used in both early and advanced stages of breast cancer. It is also used to reduce the risk of recurrence in patients who have already been treated for HER2-positive breast cancer. Trastuzumab is a widely used drug in the treatment of breast cancer, and is available from a number of pharmaceutical companies. Some of the companies that produce trastuzumab include Roche, Merck, Pfizer, and Amgen. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
